Literature DB >> 2258150

Restoration of liver function in Gunn rats without immunosuppression using transplanted microencapsulated hepatocytes.

V Dixit1, R Darvasi, M Arthur, M Brezina, K Lewin, G Gitnick.   

Abstract

Microencapsulation of cells within synthetic semipermeable membranes is a novel technique that enables the transplantation of cell cultures without the need for immunosuppression. We have previously shown that transplanted isolated encapsulated hepatocytes can provide sufficient short-term metabolic support to improve the survival of animals with galactosamine-induced fulminant hepatic failure. Here we have demonstrated the feasibility of isolated encapsulated hepatocyte transplantation in providing long-term metabolic liver support in Gunn rats. Gunn rats have a congenital inability to conjugate bilirubin and thus exhibit lifelong hyperbilirubinemia. We studied the feasibility of isolated encapsulated hepatocyte transplantation in restoring this specific liver function. Free hepatocytes, isolated from male Wistar rats, were microencapsulated with collagen within a trilayered sodium alginate-poly-L-lysine-sodium alginate membrane using techniques developed in our laboratory. A total of 45 Gunn rats underwent intraperitoneal transplantation with free hepatocytes (5 x 10(7], isolated encapsulated hepatocytes (5 x 10(7], control (empty) microcapsules or no transplant (untreated controls). Serum bilirubin levels were monitored daily for 10 days after transplantation, and subsequent weekly samples were obtained for up to 1 mo. Microcapsules were studied by light and electron microscopy 1 mo after transplantation. During the first week after transplantation, the mean maximum reduction in serum bilirubin levels for the isolated encapsulated hepatocytes, free hepatocytes and control microcapsule transplanted groups was 45.7%, 18.6% and 14.3%, respectively. For up to 1 mo thereafter the mean reduction in serum bilirubin levels in these respective groups was 34.8%, 13.5% and 3.3%.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2258150     DOI: 10.1002/hep.1840120615

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  8 in total

1.  Morphology and metabolism of Ba-alginate encapsulated hepatocytes with galactosylated poly(allyl amine) and poly(vinyl alcohol) as extracellular matrices.

Authors:  Inn-Kyu Kang; Jong-Sik Moon; Hong Myeong Jeon; Wan Meng; Yang Il Kim; Yoon Jin Hwang; Sukyoung Kim
Journal:  J Mater Sci Mater Med       Date:  2005-06       Impact factor: 3.896

Review 2.  Artificial livers--what's keeping them?

Authors:  E Davies; H J Hodgson
Journal:  Gut       Date:  1995-02       Impact factor: 23.059

Review 3.  Engineered liver for transplantation.

Authors:  Basak E Uygun; Martin L Yarmush
Journal:  Curr Opin Biotechnol       Date:  2013-06-20       Impact factor: 9.740

Review 4.  Liver cell transplantation for Crigler-Najjar syndrome type I: update and perspectives.

Authors:  Philippe-A Lysy; Mustapha Najimi; Xavier Stephenne; Annick Bourgois; Francoise Smets; Etienne-M Sokal
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

5.  Microencapsulated hepatocytes and islets as in vivo bioartificial liver support system.

Authors:  Yue Gao; Jun Xu; Bei Sun; Hong-Chi Jiang
Journal:  World J Gastroenterol       Date:  2004-07-15       Impact factor: 5.742

6.  A stereotypic, transplantable liver tissue-culture system.

Authors:  B A Naughton; B Sibanda; J P Weintraub; J San Román; V Kamali
Journal:  Appl Biochem Biotechnol       Date:  1995 Jul-Sep       Impact factor: 2.926

7.  Potentials and limitations of microorganisms as renal failure biotherapeutics.

Authors:  Poonam Jain; Sapna Shah; Razek Coussa; Satya Prakash
Journal:  Biologics       Date:  2009-07-13

Review 8.  Microencapsulation for the Therapeutic Delivery of Drugs, Live Mammalian and Bacterial Cells, and Other Biopharmaceutics: Current Status and Future Directions.

Authors:  Catherine Tomaro-Duchesneau; Shyamali Saha; Meenakshi Malhotra; Imen Kahouli; Satya Prakash
Journal:  J Pharm (Cairo)       Date:  2012-12-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.